三维融合成像优于二维点对点超声造影评估肝细胞癌射频消融后的消融边缘
该研究纳入98例肝细胞癌患者共98个病灶,比较三维超声造影融合成像与二维超声造影点对点成像评估射频消融后消融边缘(以≥5 mm为 adequate)的效能,并分析局部肿瘤进展的危险因素。三维融合成像配准时间更短(5.0 min vs 9.3 min),将二维判读为消融边缘≥5 mm的病灶中16个(26%)重新分类为<5 mm;两种方法评估的消融边缘<5 mm均与更高的3年局部肿瘤进展累积发生率相关。
要点
- 三维超声造影融合成像较二维点对点成像配准时间更短(5.0 min vs 9.3 min,p<0.0001)。
- 二维判读为消融边缘≥5 mm的病灶中,16个(26%)被三维融合成像重新分类为<5 mm。
- 二维或三维评估的消融边缘<5 mm均与更高的3年局部肿瘤进展累积发生率相关。
核心结论
- 三维超声造影融合成像在评估消融边缘方面优于二维超声造影点对点成像。
- 三维融合成像在预测局部肿瘤进展方面与二维点对点成像效能相当,且具有自动化和省时的优势。
- 三维超声造影融合成像可能作为评估消融边缘和预测射频消融后局部肿瘤进展的有效工具。
研究设计与样本
- 单中心研究,纳入98例肝细胞癌患者共98个病灶,均接受射频消融治疗。
- 术前及术后分别行二维超声造影点对点成像(手动比较术前术后二维超声造影图像)和三维超声造影融合成像(自动融合术前术后三维超声造影图像)。
- 以消融边缘≥5 mm为 adequate,比较两种技术区分 adequate 消融边缘的效能。
- 采用 Kaplan-Meier 法及 log-rank 检验分析射频消融后局部肿瘤进展的危险因素。
诊断标准与关键数值
- 消融边缘 adequate 定义为≥5 mm。
- 三维融合成像与二维点对点成像评估消融边缘的一致性 kappa 系数为0.680(p<0.0001)。
- 二维点对点成像判读为消融边缘<5 mm的病灶,三维融合成像均判读为<5 mm。
- 二维点对点成像判读为消融边缘≥5 mm的病灶中,16个(26%)被三维融合成像重新分类为<5 mm。
- 中位随访31.2个月(范围3.2-66.0个月)期间,8个肿瘤出现局部肿瘤进展,估计1年、2年、3年累积发生率分别为4.4%、8.1%、10.3%。
临床应用与阅片要点
- 三维超声造影融合成像可自动融合术前术后三维超声造影图像,配准时间较二维点对点成像更短(5.0 min vs 9.3 min,p<0.0001)。
- 二维点对点成像评估消融边缘<5 mm的肿瘤3年局部肿瘤进展累积发生率为27.2% vs 0%(p<0.001)。
- 三维融合成像评估消融边缘<5 mm的肿瘤3年局部肿瘤进展累积发生率为20.7% vs 0%(p=0.004)。
- 三维超声造影融合成像可能作为评估消融边缘和预测局部肿瘤进展的有效工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the efficiency of three-dimensional (3D) and two-dimensional (2D) contrast-enhanced ultrasound (CEUS)-derived techniques in evaluating the ablative margin (AM) after radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC).
METHODS: In total, 98 patients with 98 HCCs were enrolled. The 2D CEUS point-to-point imaging (2D CEUS-PI) was conducted by comparing the pre- and post-RFA 2D CEUS images manually, and the 3D CEUS fusion imaging (3D CEUS-FI) was conducted by fusing the pre- and post-RFA 3D CEUS images automatically. These two techniques were compared in distinguishing an adequate AM ≥ 5 mm. Risk factors for local tumor progression (LTP) after RFA were analyzed by the Kaplan-Meier method with log-rank test.
RESULTS: The mean registration time of 3D CEUS-FI and 2D CEUS-PI was 5.0 and 9.3 min, respectively (p < 0.0001). The kappa coefficient was 0.680 for agreement between 2D CEUS-PI and 3D CEUS-FI in the evaluation of AM (p < 0.0001). Tumors with AM < 5 mm by 2D CEUS-PI were all identified as AM < 5 mm by 3D CEUS-FI. Nonetheless, 16 (26%) tumors identified as AM ≥ 5 mm by 2D CEUS-PI were re-classified as AM < 5 mm by 3D CEUS-FI. During a median follow-up time of 31.2 months (range, 3.2-66.0 months), LTP was identified in 8 tumors. The estimated 1-/2-/3-year cumulative incidence of LTP was 4.4%, 8.1%, and 10.3%, respectively. Higher estimated cumulative incidence of LTP was identified in tumors with AM < 5 mm by 2D CEUS-PI (at 3-year, 27.2% vs 0%; p < 0.001), and by 3D CEUS-FI (at 3-year, 20.7% vs 0%; p = 0.004).
CONCLUSION: 3D CEUS-FI excelled in the evaluation of AM when compared with 2D CEUS-PI. With equivalent efficacy in the prediction of LTP, 3D CEUS-FI was superior to 2D CEUS-PI for its automatic and time-saving procedure.
CLINICAL RELEVANCE STATEMENT: 3D CEUS fusion imaging may serve as an effective tool in evaluating ablative margin and predicting local tumor progression after RFA in HCC.
KEY POINTS: • Both 2D and 3D CEUS-derived techniques could evaluate ablative margin (AM) after RFA for hepatocellular carcinoma. • 3D CEUS fusion imaging was more precise in the evaluation of AM compared to 2D CEUS point-to-point imaging, with advantages of its automatic and time-saving procedure. • An inadequate AM < 5 mm evaluated by CEUS-derived techniques was the only risk factor of LTP after RFA for hepatocellular carcinoma (p < 0.001 for 2D CEUS point-to-point imaging, and p = 0.004 for 3D CEUS fusion imaging).
引用
- Long H, Zhou X, Zhang X, et al. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma. Eur Radiol. 2023. PMID: 37572191. doi:10.1007/s00330-023-10023-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。